SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing significant momentum as investors position themselves ahead of the upcoming AUA plenary session, where the company is slated to present highly anticipated extended follow-up data for its prostate cancer program. The community sentiment is overwhelmingly bullish, fueled by the drug's potential as a practice-changing therapy and increasing institutional interest, while active discussions center on the possibility of a premium buyout by Big Pharma and the expectation of continued efficacy data separation.

Trio-Tech International engages in the provision of third-party semiconductor testing and burn-in services. It operates through the following segments: Semiconductor Back-End Solutions (SBS) and Industrial Electronics. The SBS segment is focused on the sale of burn-in and reliability test equipment used in the back-end manufacturing processes of semiconductors. Its equipment includes burn-in systems, burn-in boards, and related equipment that is used in the testing of structural integrity of integrated circuits. The Industrial Electronics segment consists of designing, manufacturing, and distributing a range of tests, processes, and other equipment used in the manufacturing processes of customers in various industries in the consumer and industrial market. The company was founded in 1958 and is headquartered in Los Angeles, CA.

Trio-Tech International

Trio-Tech International is trending as investors pivot from story-driven AI names to companies with verifiable semiconductor revenue, with many drawing favorable valuation comparisons to industry peers despite its smaller market cap. The community is actively discussing its potential for a re-rating, fueled by expanding AI and EV testing demand and a lean share structure that amplifies volatility.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors aggressively debate whether the current price represents a deep-value accumulation opportunity or a value trap, with community sentiment split between frustration over persistent share price weakness and conviction in the company's pivot toward agentic AI orchestration. Traders are closely monitoring a high level of short interest and significant institutional accumulation, viewing upcoming earnings as a critical catalyst to potentially break the stock out of its long-standing consolidation phase.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as the community actively discusses the stock's recent GPO partnership and potential for commercial traction, while weighing these developments against persistent concerns regarding management's history of dilution and the company's capital burn. Investors are closely monitoring weekly prescription data and upcoming earnings reports, debating whether current commercial progress justifies the stock's valuation or indicates continued financial instability.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors react to strong earnings and raised EBITDA guidance, while the community actively discusses the stock's significant long-term growth potential and its strategic importance in the ongoing global LNG supply disruption. Traders are closely monitoring the impact of Middle East geopolitical tensions and potential price target upgrades as they anticipate a breakout beyond current resistance levels.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is capturing significant investor attention following a robust quarterly performance that exceeded revenue and profit expectations, driven by the strong adoption of its oral Wegovy GLP-1 therapy. The community is actively discussing this momentum as a potential reversal of previous growth concerns, while also tracking high-volume prescription data and competitive dynamics against Eli Lilly.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

SolarEdge is experiencing significant market volatility driven by speculative options trading and broader energy sector reactions to shifting geopolitical tensions and AI-driven data center demand. Investors remain sharply divided, with a vocal community debating the stock's long-term turnaround potential versus concerns over sustained cash burn and competitive pressure.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is generating intense market discussion following a strategic pivot into high-density power solutions for AI data centers and a series of product rollouts, including its new solid-state transformer platform. While the solar sector faces ongoing macro headwinds and cyclical demand challenges, the community is actively debating whether these infrastructure-focused innovations will serve as a fundamental re-rating catalyst for the stock.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending following a significant earnings beat and raised forward guidance, with the community actively debating whether the stock's volatile price action is driven by institutional profit-taking or artificial market manipulation. Investors remain highly focused on the company's AXON AI technology and the upcoming expansion of its advertising platform, despite broader market uncertainty surrounding software sector valuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Pershing Square CEO Ackman stated that the issues dragging down the UMG stock would be addressed by this deal.</li><li>Pershing Square highlighted some of the issues weighing on UMG stock, including the postponement of UMG’s U.S. listing and the underutilization of its balance sheet, among other factors.</li><li>The company stated that UMG will be merged with Pershing Square SPARC Holdings, and the new entity will be listed on the New York Stock Exchange.</li></ul>Bill Ackman-led Pershing Square Capital Management’s (PSHZF) proposal to acquire Universal Music Group NV (UMGNF) sent UMG stock soaring on Tuesday.Pershing Square announced that UMG shareholders will receive €5.05 ($5.84) per UMG share, amounting to €9.4 billion in total.The company said the cash-and-stock deal values UMG at €30.4 per share, representing a 78% premium over Universal Music’s last closing price.<a href="https://stocktwits.com/symbol/UMGNF">UMG’s shares</a> were up nearly 11% at the time of writing.<h2 class="st-heading-2">Ackman Says Deal Would Address Issues Pulling Down UMG Stock</h2>Pershing Square CEO Bill Ackman stated that the issues dragging down the UMG stock would be addressed by this deal.“UMG's stock price has languished due to a combination of issues that are unrelated to the performance of its music business, and importantly, all of them can be addressed with this transaction,” Ackman said.Pershing Square highlighted some of the issues dragging down the UMG stock, including the postponement of UMG’s listing in the U.S., the underutilization of its balance sheet, which it says has led to reduced returns on equity, and the absence of a publicly disclosed capital allocation plan, as well as the earnings algorithm.The company also stated that there is uncertainty regarding the Bolloré Group’s 18% stake in UMG, and noted that Universal Music Group’s investor relations and communications are suboptimal.<h2 class="st-heading-2">UMG To Be Listed On NYSE Post Merger</h2>Pershing Square also stated that UMG will be merged with Pershing Square SPARC Holdings, and the new entity will be incorporated in Nevada. The merged entity will also be listed on the New York Stock Exchange, the company said.Pershing Square also added that the newly merged entity, New UMG, will publish its financial statements under U.S. GAAP and be eligible for inclusion in the S&amp;P 500 and other indexes.UMG was spun out of Vivendi in 2021, with the company’s controlling shareholder, the Vincent Bolloré-led Bolloré Group, retaining a stake. According to the Bolloré Group’s latest disclosure as of Dec. 31, 2024, it held an 18.5% stake in UMG.<a href="https://stocktwits.com/symbol/UMGNF">UMGNF stock</a> is down 15% year-to-date, while&nbsp;<a href="https://stocktwits.com/symbol/PSHZF">PSHZF stock</a> is down 17%. The&nbsp;<a href="https://stocktwits.com/symbol/ACKY">VistaShares Target 15 ACKtivist Select Income ETF</a> (ACKY) is down 11% over the past 12 months.€1 = $1.16Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-new-100-pharma-tariffs-companies-no-deal-yet/cZ7xDpiRI8S">Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bill Ackman attends Legion of Honour Award Ceremony and Dinner for Olivia Tournay Flatto at the Park Avenue Armory on October 19, 2022 in New York City. (Photo by Sylvain Gaboury/Patrick McMullan via Getty Images)

Bill Ackman-Led Pershing Square’s Acquisition Proposal Sends UMG Stock Soaring

The company said the cash-and-stock deal values UMG at €30.4 per share, representing a 78% premium over Universal Music’s last closing price.

Equity

Popstar Taylor Swift is releasing her 12th album, titled "The Life of a Showgirl," announcing the development rather casually in a podcast teaser posted on Instagram early Tuesday.Swift, the richest female musician alive with an estimated net worth of $1.6 billion, talked about the new album during a cameo on the New Heights podcast hosted by boyfriend Travis Kelce and his brother.“So I wanted to show you something,” she said, pulling a vinyl from a briefcase. “This is my brand new album, The Life of a Showgirl.” The full podcast episode&nbsp;has not been released yet, and the official album release date remains unknown.Pop Crave, a notable pop culture and media newsletter, noted that Swift created a new Spotify playlist featuring 22 songs, all of which have been produced by Max Martin and Shellback, according to an&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/PopCrave/status/1955128479349084590">X post</a>.Her new album is rumoured to be produced by the duo, according to Pop Crave.Swift’s music, with its relatable lyrics and vivid storytelling, has shaped the tastes of a generation of teenagers in the United States and worldwide. More recently, her public stands on fashion, politics, and even economics have further established her as one of the most influential artists today.Swift’s recent "Eras Tour" was the highest-grossing concert tour ever, raking in over $2.07 billion across 149 shows.The development comes over a year after the release of Swift's previous album, which dominated global charts.&nbsp;The new release is poised to boost revenue for Republic Records, one of the key labels of <a href="https://stocktwits.com/symbol/UMGNF/sentiment">Universal Music Group (UMGNF)</a>,&nbsp;which&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.nytimes.com/2025/07/22/business/universal-music-group-ipo.html">filed</a> for a U.S. initial public offering last month.Tencent owns 20% of Universal Music Group, Bill Ackman’s Pershing Square holds about 7.6%, while the Bolloré family (including Vivendi’s 10% stake) controls roughly 28%.Hilversum, Netherlands-headquartered UMG recently reported second-quarter earnings that missed estimates, partly due to weak merchandise sales, according to Bloomberg.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Taylor Swift attends the 67th Annual GRAMMY Awards on February 02, 2025 in Los Angeles, California. (Photo by Matt Winkelmeyer/Getty Images for The Recording Academy)

Taylor Swift Drops Surprise Album Reveal On Travis Kelce’s Podcast: Boost Loading For Universal Music Group?

“This is my brand new album, The Life of a Showgirl,” she said, according to a podcast teaser posted on social media. 

Taylor Swift Drops Surprise Album Reveal On Travis Kelce’s Podcast

“This is my brand new album, The Life of a Showgirl,” she said, according to a podcast teaser posted on social media. 


Universal Music Group NV engages in the music entertainment business. The firm identifies and develops artists, and produces and distributes music. It operates through the following segments: Recorded Music, Music Publishing, Merchandising and Other, and Corporate Centre. The Recorded Music offers intellectual property licenses granted by UMG to distributors or digital platforms. The Music Publishing segment relates to the use by a third party of the copyrights on musical works owned or administered by UMG. The Merchandising and Other segment represents the merchandising rights of artists and entertainment brands and properties. Its labels and brands include Abbery Road Studios, Bravado, Capitol Music Group, Decca Records, EMI, Island, and Motown. The company was founded in 1924 and is headquartered in Hilversum, The Netherlands.

Current Price	$23.62
Prev Close	$23.36
Open	$23.72
Dividend Yield	2.25%
50-Day Moving Average	$21.47
Beta	0.51
Avg. Volume	64,529.29
PE Ratio	25.44

52-Week High	$33.77
52-Week Low	$17.36
Market Capitalization	$42.94B
EPS (Annual)	$0.9439
Price to Book	8.03
Revenue Per Employee	$1.33M

UMGNF
Universal Music Group NV

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest UMGNF News

UMGNFUniversal Music Group NV